Abstract
Interorgan lipid transport occurs via lipoproteins, and altered lipoprotein levels correlate with metabolic disease. However, precisely how lipoproteins affect tissue lipid composition has not been comprehensively analyzed. Here, we identify the major lipoproteins of Drosophila melanogaster and use genetics and mass spectrometry to study their assembly, interorgan trafficking, and influence on tissue lipids. The apoB-family lipoprotein Lipophorin (Lpp) is the major hemolymph lipid carrier. It is produced as a phospholipid-rich particle by the fat body, and its secretion requires Microsomal Triglyceride Transfer Protein (MTP). Lpp acquires sterols and most diacylglycerol (DAG) at the gut via Lipid Transfer Particle (LTP), another fat body-derived apoB-family lipoprotein. The gut, like the fat body, is a lipogenic organ, incorporating both de novo–synthesized and dietary fatty acids into DAG for export. We identify distinct requirements for LTP and Lpp-dependent lipid mobilization in contributing to the neutral and polar lipid composition of the brain and wing imaginal disc. These studies define major routes of interorgan lipid transport in Drosophila and uncover surprising tissue-specific differences in lipoprotein lipid utilization.
Highlights
IntroductionIn humans, perturbed lipoprotein levels correlate with metabolic disease, but to which extent they contribute to tissue pathology is unclear
Lipoproteins allow the transport of lipids between different organs
We started our study of Drosophila lipoprotein metabolism with a genome search for potential apolipoproteins
Summary
In humans, perturbed lipoprotein levels correlate with metabolic disease, but to which extent they contribute to tissue pathology is unclear. MTP deficiency blocks secretion of apoB-containing lipoproteins, resulting in abetalipoproteinemia [4]. This causes fatty liver, intestinal lipid malabsorption, and defects in peripheral tissue function including ataxia, retinal degeneration and anemia [5]. On the other hand, elevated levels of apoB-containing lipoproteins are a hallmark of metabolic syndrome, a pathological condition comprising wide-ranging dysfunctions in different tissues. These include obesity, diabetes, heart disease and increased risk of dementia [6,7]. Advances in lipid mass spectrometry are only beginning to make such studies possible [10]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have